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Longitudinal two-photon imaging 
in somatosensory cortex of 
behaving mice reveals dendritic 
spine formation enhancement by 
subchronic administration of low-
dose ketamine
Evgeny Pryazhnikov1,2, Ekaterina Mugantseva1, Plinio Casarotto2, Julia Kolikova1, Senem 
Merve Fred  2, Dmytro Toptunov1, Ramil Afzalov1, Pirta Hotulainen  3, Vootele Voikar  2, 
Ryan Terry-Lorenzo4, Sharon Engel4, Sergei Kirov5, Eero Castren  2 & Leonard Khiroug1,2
Ketamine, a well-known anesthetic, has recently attracted renewed attention as a fast-acting 
antidepressant. A single dose of ketamine induces rapid synaptogenesis, which may underlie 
its antidepressant effect. To test whether repeated exposure to ketamine triggers sustained 
synaptogenesis, we administered a sub-anesthetic dose of ketamine (10 mg/kg i.p.) once-daily 
for 5 days, and repeatedly imaged dendritic spines of the YFP-expressing pyramidal neurons in 
somatosensory cortex of awake female mice using in vivo two-photon microscopy. We found that the 
spine formation rate became significantly higher at 72–132 h after the first ketamine injection (but not 
at 6–24 h), while the rate of elimination of pre-existing spines remained unchanged. In contrast to the 
net gain of spines observed in ketamine-treated mice, the vehicle-injected control mice exhibited a 
net loss typical for young-adult animals undergoing synapse pruning. Ketamine-induced spinogenesis 
was correlated with increased PSD-95 and phosphorylated actin, consistent with formation of new 
synapses. Moreover, structural synaptic plasticity caused by ketamine was paralleled by a significant 
improvement in the nest building behavioral assay. Taken together, our data show that subchronic low-
dose ketamine induces a sustained shift towards spine formation.
The well-known phencyclidine derivative ketamine has been in medical use as a short-term anesthetic and pain 
reliever since the 1960s1,2. Consumption of ketamine induces vivid sensations with hallucinations leading to a 
dissociative state, manifest as a sensation of detachment (dissociation) from the environment and from one’s own 
body. These properties underlie the strong potential of ketamine as a substance of abuse3,4 and, subsequently, limit 
its clinical applicability5.
The recent discovery of rapid antidepressant-like action of ketamine6,7 has revived clinical interest in this 
drug. These antidepressant effects are likely related to the newly identified pathways (other than NMDA 
receptor-mediated), which are activated either by ketamine itself8 or by its metabolic by-products9.
The synaptogenic potential of ketamine is well documented for frontal/prefrontal cortex8,10,11. In a pivotal 
work, Duman and coauthors have shown that a single intraperitoneal (i.p.) administration of ketamine in mice 
at the dose of 10 mg/kg rapidly increases synaptic protein levels and dendritic spine number in prefrontal cortex 
through activation of the mTOR signaling pathway8. The same group later demonstrated the BDNF dependence 
1Neurotar Ltd, Helsinki, 00790, Finland. 2Neuroscience Center, University of Helsinki, Helsinki, 00790, Finland. 
3Minerva Foundation Institute for Medical Research, Helsinki, 00290, Finland. 4Sunovion Pharmaceuticals Inc, 
Marlborough, MA, 01752, USA. 5Medical College of Georgia at Augusta University, Augusta, 30912, Georgia. Evgeny 
Pryazhnikov and Ekaterina Mugantseva contributed equally to this work. Correspondence and requests for materials 
should be addressed to L.K. (email: leonard.khirug@helsinki.fi)
Received: 15 August 2017
Accepted: 10 April 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific REPORTs |  (2018) 8:6464  | DOI:10.1038/s41598-018-24933-8
of the ketamine-induced rapid synaptogenesis10. Most recently, longitudinal in vivo two-photon microscopy was 
employed to show the stimulating effects of a single i.p. injection of ketamine on dendritic spine formation and 
density in medial frontal cortex of isoflurane-anesthetized mice11.
Despite the insightfulness of the above-mentioned studies, several pivotal questions remain unanswered. First, 
most studies have only tested acute administration of ketamine. While mimicking the fast and effective treatment 
of a depression episode with ketamine single dosing12, the acute administration protocol prevents implication of 
these studies’ results to situations when ketamine is administered repeatedly over the course of days or weeks. The 
reports on effects of subchronic or chronic ketamine administration on plasticity of dendritic spines are scarce13. 
Second, most reports predominantly studied the effects of ketamine on the prefrontal and frontal cortex, due 
to the depression-centered focus of these studies. It remains, therefore, unknown whether effects of ketamine 
on synaptic plasticity can be generalized to other cortical areas. Third, some of the previous studies relied on 
end-point techniques while others used anesthetics (such as isoflurane) during in vivo microscopic analysis of 
spines, which may have significantly affected the outcome of experiments14,15. Some depressed patients do not 
respond to a single dose of ketamine but have been able to achieve additional benefits with additional doses16. 
Therefore, the main purpose of this study was to extend on the previous bodies of work by quantifying the effects 
of multiple-dose sub-anesthetic ketamine on spine turnover in somatosensory cortex under the best-achievable 
physiological conditions, i.e., in awake behaving animals.
Two-photon microscopy provides the highest spatial resolution in vivo and allows repetitive imaging of the 
same cells (and subcellular structures) over the course of days or weeks. In this study, we monitored the formation 
and elimination rates of mature “mushroom”-shaped spines17 on apical dendrites of Layer IV-V cortical neurons 
in the somatosensory cortex. We investigated in awake behaving mice whether subchronic administration of 
low-dose ketamine induces long-lasting changes in the dendritic spine turnover in somatosensory cortex.
Methods
All animal procedures were performed in accordance with the University of Helsinki animal care regulations. 
Local authority (ELÄINKOELAUTAKUNTA-ELLA) approved the animal license (ESAVI/6828/04.10.07/2013) 
to conduct the procedures described in the study.
Behavioral tests. The animals (15 female C57BL/6JRccHsd WT mice; 10 week old at the start of the 
experiment) were group housed. Shortly before the start of behavioral tests mice were moved to type II cages 
(267 × 207 × 140 mm) with bedding material (aspen chips, Tapvei, Harjumaa, Estonia), and a 2.5 g compressed 
cotton cloth (50 × 50 mm; Ancare, Bellmore, USA). Mice were single-housed in these cages for the whole dura-
tion of behavioral tests. The nest building was scored according to18. Briefly, the nest was analyzed for the amount 
of shredded material and its shape: 1 = nestlet >90% intact; 2 = nestlet 50–90% intact; 3 = nestlet mostly shred-
ded but no identifiable nest site; 4 = identifiable but flat nest; 5 = crater-shaped nest. Following an undisturbed 
7 day acclimation period, the nest building score (NBS) was determined and the animals were injected with keta-
mine (10 mg/kg; n = 8) or vehicle (PBS; 10 ml/kg; n = 7), and the NBS was assessed 22 h after each drug injection 
(1 daily injection; 4 days) by an observer blinded to the treatment. After each scoring session, the nest material 
was removed and a new cloth introduced.
During the experimental procedures the animals’ activity was monitored by InfraMot system (TSE, Bad 
Homburg, Germany), in blocks of 22 h. This system, mounted on top of the cage cover, detects the heat radiating 
from the animal’s body and its displacement over time. Food and water were available ad libitum during the whole 
experiment, except during cage cleaning and substitution of cotton cloths.
Animal surgery and treatment. Female 4–10 weeks old B6.Cg-Tg(Thy1-YFP)HJrs/J mice (mouse strain 
003782, JaxLab) were anesthetized with ketamine/xylazine and operated for implantation of a cranial window. 
The cranial window was inserted over the somatosensory cortex at the following coordinates: AP −1.8, ML −2.0 
from Bregma. Dental drill (HP4–917, Foredom) was used to remove a round-shaped (d = 4 mm) piece of skull, 
and the hole in the bone was covered with a round cover glass (d = 5 mm; #72296–05, Electron Microscopy 
Sciences). Helicopter shaped headplate (model 1; Neurotar) was placed over the cover glass and fixed with dental 
cement (Rapid Repair; Dentsply) mixed with cyanoacrylate glue (Loctite 401; Henkel) to a skull surface. Based on 
the transparency of the cranial window 4 weeks after implantation, in total 29 mice were selected for the imaging 
study and divided randomly in two2 groups. Approximately 50% of operated mice were found suitable for imag-
ing. All treatments were by a single i.p. injection at 10 mg/kg per day for 5 consecutive days. The first i.p. injection 
of ketamine or vehicle was done on day 1, thirty minutes after the baseline imaging session was completed (or at 
about 2 hours after the start of imaging time 0). Subsequent injections of ketamine or vehicle were performed at 
the 25 h, 49 h, 73 h and 97 h time points after the first injection. The vehicle consisted of Phosphate Buffered Saline 
(PBS), containing (in mg/L): 144.00 KH2PO4, 9000.00 NaCl, 795.00 Na2PO4. We used the 10 mg/kg i.p. dose, 
because it is has been associated with synaptogenic effects in rodents8 and results in plasma exposures that closely 
reflect those observed in the clinic8,19,20.
Two-photon imaging. Mice were imaged with the FV1200MPE two-photon microscope (Olympus, Japan) 
with the 25X water immersion 1.05 NA objective specially designed for in vivo two-photon imaging. MaiTai 
Broad Band DeepSee laser tuned to 900 nm was used for excitation. Emission light was collected using a band 
pass filter (515–560 nm).
For in vivo imaging sessions, awake animals were head-fixed under two-photon microscope using Mobile 
HomeCage device (Neurotar, Finland). Prior to the imaging sessions, animals were habituated to head fixation 
in eight(8) two-hour training sessions. Three-dimensional (3D) baseline YFP fluorescence image Z-stacks of the 
apical dendrites of layer 5 pyramidal neurons in somatosensory cortex were acquired. Although the cell body 
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location of pyramidal neurons was not confirmed in this study, the YFP-H cell line was chosen in part because 
YFP expression is largely restricted to Layer 5 neurons21. Stacks of images were collected with the vertical step of 
1 µm (total imaged thickness of stacks: 30–70 µm) with zoom factor three at 800 × 800 or 512 × 512 pixels aspect 
ratio. Each imaging area spanned 166.7 × 166.7 µm in the field of view. The baseline image stacks (up to 8 stacks 
per animal) were acquired during the 30–120 min time window before the first injection of vehicle or ketamine. 
Two subsequent imaging sessions were performed at 24 h and 72 h. The final session was performed either at 120 h 
(11 mice) or at 144 h (11 mice); the data from this last time point were pooled, the time window binned and the 
time point designated as the “132 h” point. The total number of imaging sessions per animal was five.
Imaging depth extended to cortical layers 1 and 2; based upon the known Layer 5 neuron morphology, the 
dendritic spines used for turnover quantification were located predominantly in the apical dendrite tufts. For 
acquisition, horizontally-oriented dendrites were favored as the x-y resolution of two-photon microscopy is 
inherently higher than the z resolution. At least 150 dendritic spines were captured at each time point. These 
spines were collected from the dendrites of multiple different neurons.
Image Analysis. After acquisition, the images were processed and analyzed using Imaris (Bitplane, United 
Kingdom) and Fiji/ImageJ (open source image processing package, NIH, USA) software. Shifts of tissue in x, y 
and z directions were compensated using dedicated plugins in the Fiji software. Spine turnover analysis was per-
formed by independent scientist blinded to the identity of the treatment groups. Individual spines were tracked 
by visually comparing the spine’s morphology in the stacks of images collected at each of the five time points. 
Dendritic spines were counted if they protruded for at least 0.5 microns from the dendritic shaft. Only mature, 
“mushroom”-like spines with head diameters much greater than their neck diameters17 were counted. Our aim 
was to quantify the turnover of 150–200 dendritic spines per animal. Each spine was assigned with a specific code 
at every time-point: either 1 (present) or 0 (absent). Special attention was paid to exclude pseudo-elimination 
and/or formation of spines due to shift or rotation of spine in z-direction. For this purpose at least 10 additional 
slices were visually checked in “up” and “down” direction for every time-point for every spine. At least 125 spines 
per animal were analyzed for spine density analysis. The data were normalized to pre-treatment baseline. After 
visual analysis, the data were transferred to “R” software, Microsoft Excel and Microcal Origin for statistical anal-
ysis and plotting of graphs.
Western blotting. For western blot experiments we used 15 female mice randomly distributed between 
three treatment groups: i) group 1 received daily i.p. injections of ketamine (10 mg/kg; n = 5) for 3 consecutive 
days; ii) group 2 received two consecutive injections of vehicle and one injection of ketamine (10 mg/kg; n = 5); 
iii) group 3 received daily i.p. injections of vehicle (10 mg/kg; n = 5) for 3 consecutive days. Thus the resulting 3 
groups were termed as follows: i) ketamine 72 h (n = 5); ii) ketamine 24 h (n = 5) and iii) vehicle (n = 5). On day 
4 all 15 animals were euthanized with incremental CO2 concentration (up to 20%).
The somatosensory cortex was dissected, and immediately frozen on dry ice. The samples were sonicated on 
lysis buffer [20 mM Tris-HCl – pH = 8.0; 137 mM NaCl, 48 mM NaF, 1% Nonidet-40, 10% glycerol; supplemented 
with protease inhibitor cocktail – Roche Complete; and 2 mM Na3VO4] and centrifuged 10000xg/15 min. The 
supernatant was collected, the total protein levels were determined by Lowry method, and stored at −80 °C until 
use.
The samples (50 µg of total proteins) were resolved in SDS-PAGE gradient gels (4–12%; NuPAGETM Novex; 
Invitrogen; USA) and transferred to polyvinylidene difluoride membrane (PVDF). The membranes were blocked 
in 3% BSA-TBST [50 mM Tris, 150 mM NaCl, pH 7.6, 0.1% Tween20], and incubated with the following primary 
antibodies against phospho-actin (Y53; 1:1000; ECM Biosciences), PSD-95 (1:1000; Santa Cruz, #sc32290), NR2B 
(1:2000; Chemicon, #ab1557) and GAPDH (1:5000; Santa Cruz, #sc25778) overnight at 4 °C. Then, the membrane 
were briefly washed with TBST and incubated with HRP-conjugated secondary antibody (BioRad, #170–5046, 
#170–5047; 1:10000) for 1 hour at room temperature. The luminescence obtained after incubation with ECL was 
detected by a CCD camera (G:BOX, Syngene, UK). The images were analyzed using ImageJ software v1.47. The 
optical density for each targeted protein was normalized by GAPDH signal and expressed as percentage of the 
control group (vehicle).
Experimental Design and Statistical Analysis. Overall, 54 mice (25 wild-type C57BL/6JRccHsd 
mice and 29 heterozygous B6.Cg-Tg(Thy1-YFP)HJrs/J transgenic mice obtained from the same strain of origin 
C57BL/6J) were used for imaging, behavioral analysis and molecular biology in this study, as summarized in the 
Table 1. Out of the 29 mice used for imaging, 22 mice were included in the paper based on the exclusion criteria 
described below.
For animal allocation to the imaging experiments, randomization was performed prior to starting the experi-
ments by one of the co-authors blinded to the group identity. The group allocation codes were concealed from the 
other co-authors performing the manual spine analysis, until the final step of data pooling and statistical analysis. 
The exclusion criteria for imaging experiments were as follows: animals were excluded from data analysis based 
on an insufficient quality of images judged by one of the co-authors performing manual spine analysis, who was 
blinded to the group identities. Blinding and randomization procedures used in two-photon imaging experi-
ments in this study have been thoroughly evaluated during an on-site audit on March 22, 2016 by Partnership for 
Assessment and Accreditation of Scientific Practice (PAASP GmbH, Heidelberg, Germany) and were confirmed 
to be carried out as described in the manuscript.
For randomization of behavioral and molecular biology experiments, care was taken to allocate mice from the 
same group-housing cage to different treatment groups as evenly as possible.
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mouse # sex date of birth weight, g surgery date treatment
date of the 





jk11 f 29.9.2014 15 3.11.2014 Ketamine 8.12.2014 — —
Excluded from 
analysis due to lower 
quality of the images
jk29 f 29.9.2014 15 7.11.2014 vehicle 1.12.2014 — —
jk31 f 30.9.2014 16 14.11.2014 vehicle 17.12.2014 — —
jk38 f 27.9.2014 15 11.11.2014 vehicle 10.12.2014 — —
Excluded from 
analysis due to lower 
quality of the images
jk39 f 27.9.2014 15 12.11.2014 Ketamine 10.12.2014 — —
Excluded from 
analysis due to lower 
quality of the images
jk43 f 28.9.2014 15 12.11.2014 Ketamine 19.1.2015 — —
jk44 f 28.9.2014 16 11.11.2014 vehicle 14.1.2015 — —
jk46 f 30.9.2014 17 18.11.2014 Ketamine 7.1.2015 — —
jk61 f 11.10.2014 18 5.12.2014 vehicle 12.1.2015 — —
jk65 f 29.9.2014 17 5.12.2014 Ketamine 12.1.2015 — —
jk86 f 25.11.2014 15 29.12.2014 Ketamine 21.1.2015 — —
jk95 f 23.11.2014 14 23.12.2014 vehicle 21.1.2015 — —
jk124 f 25.11.2014 14 31.12.2014 vehicle 26.1.2015 — —
Excluded from 
analysis due to lower 
quality of the images
jk128 f 25.11.2014 13 2.1.2015 Ketamine 28.1.2015 — -
jk549 f 12.5.2016 19 4.7.2016 vehicle 9.8.2016 — —
Excluded from 
analysis due to lower 
quality of the images
jk558 f 13.5.2016 15 1.7.2016 Ketamine 9.8.2016 — —
jk591 f 17.5.2016 18 6.7.2016 Ketamine 16.8.2016 — —
jk593 f 17.5.2016 16 7.7.2016 vehicle 16.8.2016 — —
jk610 f 19.5.2016 20 3.8.2016 vehicle 30.8.2016 — —
Excluded from 
analysis due to lower 
quality of the images
jk640 f 20.6.2016 19 4.8.2016 Ketamine 13.9.2016 — —
jk654 f 22.6.2016 19 12.8.2016 vehicle 13.9.2016 — —
jk690 f 28.6.2016 18 16.8.2016 vehicle 20.9.2016 — —
jk692 f 28.6.2016 18 16.8.2016 Ketamine 20.9.2016 — —
jk694 f 28.6.2016 17 18.8.2016 vehicle 20.9.2016 — —
jk703 f 29.6.2016 18 23.8.2016 Ketamine 27.9.2016 — —
jk706 f 29.6.2016 19 23.8.2016 Ketamine 27.9.2016 — —
Excluded from 
analysis due to lower 
quality of the images
jk723 f 2.7.2016 20 29.8.2016 vehicle 4.10.2016 — —
jk726 f 3.7.2016 16 1.9.2016 Ketamine 4.10.2016 — —
jk734 f 6.7.2016 20 2.9.2016 vehicle 4.10.2016 — —
NS-JK378 f 7–13.12.2015 20 — Ketamine — 15.02–19.02.2016 —
NS-JK379 f 7–13.12.2015 18 — Ketamine — 15.02–19.02.2016 —
NS-JK380 f 7–13.12.2015 18 — Ketamine — 15.02–19.02.2016 —
NS-JK381 f 7–13.12.2015 20 — Ketamine — 15.02–19.02.2016 —
NS-JK382 f 7–13.12.2015 18 — Ketamine — 15.02–19.02.2016 —
NS-JK383 f 7–13.12.2015 16 — Ketamine — 15.02–19.02.2016 —
NS-JK384 f 7–13.12.2015 16 — Ketamine — 15.02–19.02.2016 —
NS-JK385 f 7–13.12.2015 19 — Ketamine — 15.02–19.02.2016 —
NS-JK386 f 7–13.12.2015 20 — vehicle — 15.02–19.02.2016 —
NS-JK387 f 7–13.12.2015 18 — vehicle — 15.02–19.02.2016 —
WB-NS-JK388 f 7–13.12.2015 19 — vehicle — 15.02–19.02.2016 11.3.2016
WB-NS-JK389 f 7–13.12.2015 16 — vehicle — 15.02–19.02.2016 11.3.2016
WB-NS-JK390 f 7–13.12.2015 18 — vehicle — 15.02–19.02.2016 11.3.2016
WB-NS-JK391 f 7–13.12.2015 21 — vehicle — 15.02–19.02.2016 11.3.2016
WB-NS-JK392 f 7–13.12.2015 16 — vehicle — 15.02–19.02.2016 11.3.2016 Excluded from WB
WB-JK393 f 7–13.12.2015 21 — Ketamine 24 h — — 11.3.2016
WB-JK394 f 7–13.12.2015 20 — Ketamine 24 h — — 11.3.2016
WB-JK395 f 7–13.12.2015 20 — Ketamine 24 h — — 11.3.2016
Continued
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The analysis of nest building score (n = 8 mice for ketamine group, n = 7 mice for vehicle group) was per-
formed using a two-way ANOVA with repeated measures, having drug treatment and nest score along time as 
factors, and Sidak’s post hoc test when appropriated. The p < 0.05 values were considered significant.
For dendritic spine analysis (n = 11 mice for ketamine group, n = 11 mice for vehicle group), normality of the 
data was tested using Shapiro-Wilcoxon test of normality. In those cases when data were found to be normally 
distributed, comparison with 0 (baseline) was performed using Student’s t-test, otherwise Wilcoxon signed rank 
test was used. For the “formation”, “elimination” and “mobile fraction” parameters, we used the “greater than” 
version of the statistical test (because all of these values are >=0). For the “net change” parameter, the “two-sided” 
version of the test was used. The p < 0.05 values were considered significant. The comparisons between groups 
within a particular time interval were made using a non-parametric Mann-Whitney rank sum test. In all data 
analysis individual animal served as a statistical unit.
The western blotting data (n = 5 mice for vehicle group, n = 5 mice for ketamine 24 h group and n = 5 mice for 
ketamine 72 h group) were analyzed by one-way ANOVA followed by the Newman-Keuls or Fisher’s LSD post hoc 
tests when appropriate. The p < 0.05 values were considered significant.
Data availability statement. The datasets generated during and/or analyzed during the current study are 
available from the corresponding author on reasonable request.
Results
Subchronic ketamine improves nest-building behavior without affecting total activity 
level. We started by analyzing the effects of the drug on the animal behavior and well-being. In the test proto-
col (see Fig. 1A, upper panel) ketamine was applied daily over the course of 4 days starting from Day 1, and the 
mouse behavior was monitored daily starting from the second day of injections. In the control mice subjected to 
the nest building test designed for assessment of animal well-being22, we observed a gradual reduction in the nest 
building activity. This small decline in nest score is consistent with mild deterioration in the mouse’ well-being, 
possibly associated with frequent handling and/or i.p. injections. Against this background, sub-anesthetic keta-
mine caused a sustained improvement in the nest building score, which became statistically significant starting 
already from Day 2, i.e. from the second day of the test, and remained at the significant level through Day 5 (see 
Fig. 1B). This finding suggests that repeated administration of low-dose ketamine improved well-being of sin-
gle-housed mice. To exclude the possibility that this effect was due to an increased non-specific overall activity 
of mice, we monitored activity of the animals (see Methods for description) and found that the total activity was 
not affected by ketamine (Fig. 1C). Together, our behavioral data confirmed that the chosen protocol induces 
detectable changes in animal behavior and well-being.
Dendritic spine turnover in somatosensory cortex under control conditions. We then asked 
which synaptic and molecular events are associated with the observed changes in the cortex of young-adult mice. 
Three weeks after the implantation of cranial windows in YFP-H mice (see Methods for description of the pro-
cedure), we selected 29 animals with transparent cranial windows (Table 1) and habituated them for Mobile 
HomeCage device (see Fig. 2A) during 4 days of training sessions (see ref.23 for full description of habituation 
protocol). Upon image acquisition, dendritic spines were tracked blind to experimental conditions (see Fig. 2B–D 
for examples of spines) and statistical analysis was performed using the following four parameters: (i) forma-
tion, i.e. fraction of the spines that were newly formed (“gained”) during a given time interval (green arrow in 
Fig. 2C); (ii) elimination, i.e. fraction of the spines that have disappeared (were “lost”) during a given time interval 
(magenta arrow in Fig. 2D); (iii) net change, i.e. difference between the “formation” and “elimination” fractions, 
and (iv) mobile fraction, i.e. sum of the “formation” and “elimination” fractions. These four parameters are among 
the most commonly analyzed and presented in the publications focusing on the turnover of dendritic spines23–25.
In the control YFP-H mice, spine elimination prevailed over formation, which resulted in a statistically signif-
icant net loss of spines (1.0 ± 0.4% for the 24–72 h interval, and 1.5 ± 0.6% for the 72–132 h interval; black bars 
in Fig. 3C; see Table 2 for statistical comparison against baseline). This observation is consistent with the synapse 
pruning reported to occur in adolescent/young-adult mice26,27.
Subchronic ketamine administration boosts spine formation. We used two common ways of quan-
tifying the spine dynamics: 1) cumulative (i.e., change in spines between the pre-treatment baseline and a certain 
time point), and 2) inter-session (i.e., change in spines between two subsequent imaging sessions). The analysis of 
mouse # sex date of birth weight, g surgery date treatment
date of the 





WB-JK396 f 7–13.12.2015 17 — Ketamine 24 h — — 11.3.2016
WB-JK397 f 7–13.12.2015 17 — Ketamine 24 h — — 11.3.2016
WB-JK398 f 7–13.12.2015 21 — Ketamine 72 h — — 11.3.2016
WB-JK399 f 7–13.12.2015 17 — Ketamine 72 h — — 11.3.2016
WB-JK400 f 7–13.12.2015 18 — Ketamine 72 h — — 11.3.2016
WB-JK401 f 7–13.12.2015 20 — Ketamine 72 h — — 11.3.2016
WB-JK402 f 7–13.12.2015 19 — Ketamine 72 h — — 11.3.2016
Table 1. Summary of subjects used and disqualified, metrics and treatments.
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the effects of ketamine on spine formation (“gain”) showed that, using both cumulative and inter-session metrics, 
there was significantly more newly-formed spines in ketamine-treated group compared to the control animals 
(Fig. 3A). Thus, in the control group there were only a few newly formed spines (around 1.5% cumulatively for 
0–132 h; p < 0.001 relative to baseline; black bars in Fig. 3A), and the ketamine treatment nearly doubled the 
spine formation (2.6 ± 0.3% cumulatively for the 0–132 h; p < 0.001 as compared to the baseline, and p = 0.019 
as compared to the control group; red bars in Fig. 3A). The inter-session analysis confirmed that spine formation 
rates were significantly higher in ketamine-treated mice compared to control (1.0 ± 0.2% versus 0.4 ± 0.1% for 
the 24–72 h interval; p = 0.0015, Fig. 3A). These data demonstrate that low-dose subchronic ketamine is a potent 
stimulator of dendritic spine formation.
Subchronic ketamine has no effect on spine elimination. As mentioned above, in the vehicle-treated 
group, the spine elimination (“loss”) was more pronounced than spine formation. We calculated the effects of the 
subchronic ketamine treatment on spine elimination (Fig. 3B), and found that the continuous spine elimination 
was very similar between the control and ketamine-treated groups throughout the whole duration of the imaging 
experiments (132 h). Thus, cumulative spine elimination in both vehicle-treated and ketamine-treated mice dur-
ing the 0–72 hour interval was significantly different from the baseline (see Table 2), but the there was no differ-
ence between these groups in terms of spine elimination (p = 0.2143; Fig. 3B). These data indicate that subchronic 
low-dose ketamine has no effect on spine elimination in mouse somatosensory cortex.
Ketamine treatment reverses net loss of spines and induces net gain. A common way of quantify-
ing spine turnover is calculating the net effect of spine formation and elimination, by subtracting the percentage 
of “lost” spines from the percentage of “gained” spines. The resulting values, when positive, represent a “net gain” 
of spines, which is characteristic of the rapid synaptogenesis observed during the early postnatal period; when 
negative, the net values represent a “net loss” typical for the adolescent/young-adult animals undergoing synapse 
pruning; the near-zero values correspond to the “net equilibrium” observed in adult animals.
The cumulative net changes in spines are shown in Fig. 3C (left panel), and the inter-session net changes are 
shown in Fig. 3C (right panel). The vehicle-treated group demonstrates a strong trend towards the net loss of 
spines over the course of our study, reaching a near-significant level by 132 h (p = 0.061 for 0–132 h, see Table 2). 
The net change in the control group was found to be significantly different from the baseline at the 24–72 h time 
and at 72–132 h interval (p = 0.023 for 24–72 h and p = 0.029 for 72–132 h, Table 2). Ketamine treatment reversed 
the net loss of spines observed in the control group; instead, a significant net gain of spines was observed in the 
ketamine group during the 0–72 h time interval (Table 2). The differences between the two groups were statisti-
cally significant (p < 0.05 for three time intervals: 0–72 h, 0–132 h and 24–72 h; Fig. 3C).
Ketamine does not affect the mobile (unstable) fraction of spines. Calculating the “mobile frac-
tion” is another way of assessing spine turnover, which quantifies the percentage of spines that are unstable (i.e., 
are either lost or gained during a given time interval). This metrics allows the assessment of a “destabilizing”, or 
“mobilizing”, effect of a treatment on dendritic spines. Our calculations of the mobile fraction show that the per-
centage of unstable spines was statistically indistinguishable between the vehicle- and ketamine-treated groups 
(Fig. 3D). Cumulatively, both groups showed the mobile fraction values around 3–5%, which were significantly 
Figure 1. (A) Timeline of behavioral and two-photon imaging experiment. Abbreviations: KET – ketamine 
injection, NS – nest score, IM – imaging session. (B) Effect of ketamine treatment on nest building score, 
a.u. - arbitrary units; (C) Effect of ketamine treatment on total animal activity. See full details in Materials and 
methods section. *Indicates p < 0.05.
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different from the pre-treatment baseline (p < 0.01 beginning from the 0–24 h time interval; Table 2) but not 
different between the groups (p > 0.05 for all time-points; Fig. 3D).
Ketamine transiently increases spine density. In addition to spine turnover, we also calculated 
the spine density at each imaging time point (Fig. 3E). Interestingly, two groups showed opposite trends: 
ketamine-treated mice tended to increase their spine density, while in vehicle-treated mice the density tended to 
decrease. However, spine density in both vehicle-treated and ketamine-treated mice was not significantly differ-
ent from the baseline (see Table 2), but the there was a statistically significant difference in terms of spine density 
between these groups during the 0–24 h interval (p = 0.024; Fig. 3E). This is consistent with our finding that 
subchronic ketamine reverses net loss of spines observed in vehicle-treated mice (Fig. 3C).
Taken together, the spine imaging data demonstrate that, under the control conditions, spine elimination 
prevails over spine formation, resulting in net loss of spines, and that subchronic ketamine treatment increases 
spine formation, resulting in net equilibrium and, at some time points, net gain of spines. Consistently, ketamine 
increases spine density but does not affect the size of mobile fraction of spines.
Ketamine treatment elevates protein levels for phospho-actin and PSD-95 but not NR2B. To 
elucidate possible molecular mechanisms underlying the stimulating effects of ketamine on spine formation, 
we analyzed ex vivo brain tissues harvested from somatosensory cortices and measured the level of key pro-
teins associated with synaptic plasticity. Pharmacologically, the primary mechanism of ketamine action is its 
non-competitive antagonism of NMDA-type glutamate receptors28. Antagonists of the NR2B subunit of the 
NMDA receptors have been shown to possess antidepressant-like activity comparable to ketamine29 and knock-
down of NR2B mimics antidepressant effects of ketamine30,31. We observed a trend towards reduced expression of 
NR2B subunit in ketamine-treated mice; however, this effect did not reach significance (p > 0.05; Fig. 4).
Figure 2. (A) Overview of a Mobile HomeCage platform used for head fixation of awake behaving mice (top 
image) and images of a mouse head-fixed in the platform under an objective during a typical two-photon 
imaging session (middle and bottom images). (B) Maximum intensity projection of 26 slices from z-stack of 
images showing typical architecture of layer V apical dendrites in somatosensory cortex in Thy1-YFP mice. 
Sequences of images showing examples of formation (C) of a new spine and elimination (D) of existing spine at 
132 h time-point.
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It was shown earlier that brief over-expression of an actin phosphorylation-mimicking mutant construct 
increased the dynamics of dendritic spines32. At the same time, over-expression of the phospho-mimicking actin 
construct increased the sizes of synapses, on both pre- and postsynaptic sites, suggesting that actin phosphoryla-
tion facilitated synapse formation. We measured the level of actin phosphorylated on residue Y53 and found that 
it increased 33 ± 11% by 24 hours and 47 ± 13% by 72 hours after the first ketamine injection (Fig. 4).
PSD-95 is known to be associated with mature excitatory synapses33. Our Western blot analysis showed that 
the expression level of PSD-95 increased by 72 hours (i.e. at the time point where we observed significant effects 
of ketamine on spine turnover) after the first ketamine injection (28 ± 8% increase at 72 h, p < 0.05; Fig. 4).
Our findings of increased PSD-95 and phosphorylated actin, taken together with the boost in dendritic spine 
formation, strongly suggest that subchronic ketamine administration induces sustained changes in synaptic 
plasticity.
Discussion
To the best of our knowledge, this is the first study quantifying the effects of subchronically administered keta-
mine on spine turnover in awake, behaving mice. The main finding of this study is that repetitive administration 
of ketamine induced a sustained shift in dendritic spine turnover towards spine formation and promoted syn-
aptogenesis by increasing phosphorylated actin (pY53) and elevating PSD-95 expression. Taken together, our 
biochemical and anatomical data complement each other in demonstrating that (and suggesting how) subchronic 
ketamine induces synaptic plasticity in somatosensory cortex.
Recent clinical studies indicated that repeated ketamine infusions achieved superior outcomes as compared 
to a single infusion16,34,35. The preclinical data presented here support the utility of repeated ketamine infusions 
for greater efficacy in clinical settings.
The present study was designed to test both general effects of ketamine on the animal’s wellbeing and behavior 
as well as its effects on cellular and molecular mechanisms. Nest building activity is an indicator of health and 
welfare in laboratory mice36. The improvement in the nest building score we observed with subchronic keta-
mine administration suggests the general positive influence of this treatment on laboratory mice. However, the 
observed effect of ketamine cannot be extrapolated to any specific pathological condition, because the nest build-
ing test is not generally used as an assay for depression or stress.
The present data also show that the structural remodeling observed previously with ketamine treatments10 
is not limited to frontal/prefrontal cortex. A comparison between our study and the recently published in vivo 
data from the medial frontal cortex11 highlights both similarities and differences. On the one hand, in both cases 
ketamine elevated the spine formation rate; on the other hand, in our study the stimulating effect of ketamine on 
Figure 3. Effects of ketamine (red bars) and vehicle (black bars) treatment on spine formation (A), spine 
elimination (B), net gain/loss (C), mobile fraction (D) and spine density (E) as compared to baseline (left 
panel of each image) or preceding time-points (right panel of each image). Statistical P values for inter-
group comparisons are shown in the Figure. See Table 2 for statistical data on comparisons with baseline (0 h 
timepoint).
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Data structure Type of test p value
Quantification of dendritic spine 
turnover (n = 11 mice for ketamine 
group, n = 11 mice for control group), 
comparison with baseline(0)
Test for normality of data distribution was performed 
for each data set. In the right-side column of this 
table, only t-test values are shown for normally 
distributed data sets, and only Wilcoxon signed rank 
test values are shown for the remaining data sets.
Vehicle treatment
Comparison group t-test Wilcoxon
Elimination 0–24 h 0.01112706
Elimination 0–72 h 4.776974e−4
Elimination 0–132 h 8.629025e−4
Elimination 24–72 h 5.64133e−4
Elimination 72–132 h 1.653414e−3
Formation 0–24 h 9.692149e−4
Formation 0–72 h 9.277724e−4
Formation 0–132 h 8.739528e−4
Formation 24–72 h 0.010068376
Formation 72–132 h 0.011007467
Net 0–24 h 0.16228664
Net 0–72 h 0.3647341613
Net 0–132 h 0.06097509
Net 24–72 h 0.0231812
Net 72–132 h 0.028517536
Mobile 0–24 h 1.885146e−3
Mobile 0–72 h 1.885146e−3
Mobile 0–132 h 8.586481e−5
Mobile 24–72 h 4.043268e−5
Mobile 72–132 h 7.491859e−4
Density 0–24 h 0.371093
Density 0–72 h 0.769134
Density 0–132 h 0.765564
Density 24–72 h 0.554025
Density 72–132 h 0.885468
Ketamine treatment
Comparison group t-test Wilcoxon
Elimination 0–24 h 0.02952911
Elimination 0–72 h 0.011127062
Elimination 0–132 h 2.506081e−4
Elimination 24–72 h 3.804348e−3
Elimination 72–132 h 1.911177e−3
Formation 0–24 h 2.5775378e−3
Formation 0–72 h 9.406125e−5
Formation 0–132 h 6.758756e−6
Formation 24–72 h 4.545349e−3
Formation 72–132 h 2.44514e−5
Net 0–24 h 0.13569602
Net 0–72 h 5.643972e−4
Net 0–132 h 0.91243574
Net 24–72 h 0.8663546
Net 72–132 h 1.866831e−3
Mobile 0–24 h 7.750874e−4
Mobile 0–72 h 5.193477e−4
Mobile 0–132 h 2.294916e−5
Mobile 24–72 h 3.520205e−5
Mobile 72–132 h 8.882077e−6
Density 0–24 h 0.100348
Density 0–72 h 0.332934
Density 0–132 h 0.529371
Density 24–72 h 0.590639
Density 72–132 h 0.498503
Table 2. Statistical data.
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spine formation in the somatosensory cortex reached significance only 72 hours after the first injection (Fig. 3), 
while in the frontal cortex ketamine’s effect was significant already at 24 hours11. This comparison suggests a faster 
rate of development of the effect of systemic ketamine in the frontal cortex versus somatosensory. However, one 
should also take into account the methodological differences between the two studies: namely, single injection of 
ketamine versus subchronic administration, and imaging in anesthetized versus awake animals.
An important advantage of the present study is that it was performed under the conditions of minimal inva-
siveness (chronic cranial windows over somatosensory cortex) and maximal physiological relevance (longitudi-
nal imaging in awake behaving mice). To overcome limitations of general anesthesia and to avoid the negative 
side-effects of the stress associated with full-body animal restraint, we used a recently developed air-lifted plat-
form for imaging the brain of head-fixed but otherwise freely moving and behaving animals37,38. We started 
spine imaging no sooner than 3–4 weeks after the cranial window surgery, and selected only those mice that had 
transparent windows and showed no signs of residual post-surgical inflammation (see the Standard Operation 
Procedures described in the Methods section). The somatosensory cortex area was selected for several reasons: a) 
it is not known whether synaptogenic effects of ketamine occur beyond frontal/prefrontal cortex; b) somatosen-
sory cortex can be imaged in vivo without a major surgery that may cause substantial damage to brain tissue (as 
occurs with glass prism implantation); c) several studies have shown that dissociative effect of ketamine is accom-
panied by a functional disruption of cortico-cortical pathways39,40, which may lead to restructuring of synaptic 
pathways in somatosensory cortex; d) being a primary site for decoding proprioceptor and nociceptor informa-
tion41, somatosensory cortex may serve as a relevant area for ketamine-induced plastic changes in the brain.
Another feature of our study consists in the special efforts that were made to minimize possible biases dur-
ing both imaging and data analysis. First, mice of only one gender were used in this study. Second, mice were 
carefully selected for imaging based on the transparency of their cranial windows. Third, the selected mice were 
randomized before the start of the imaging procedure. Fourth, the researcher performing analysis of individual 
dendritic spines was blinded to the identity of the treatment groups; the whole image sequence data were analyzed 
by one person to minimize possible inter-person variability in the spine counting method. Finally, individual 
animals, rather than spines or imaging areas, served as experimental units for statistical analysis.
However, this study has several limitations. First, imaging was limited to one week, and possible long-term 
changes in the spine turnover were not studied after the cessation of ketamine treatment. Second, while this study 
expands our knowledge on synaptogenic effects of ketamine beyond prefrontal cortex, we had to limit the scope 
of our experiments to only one cortical region (somatosensory). Third, the limited size of this study did not allow 
us to compare the effects of a single dose of ketamine with those of subchronic administration, which should be 
addressed in future studies.
This study was performed in young adult mice (2–3 months of age) that are known to undergo synaptic prun-
ing, i.e. at the age when in layer 5 pyramidal neurons of somatosensory cortex elimination of synapses prevails 
over their formation26,27. The re-balancing effect of ketamine on synaptic inputs may underlie some of the com-
plex behavioral effects of ketamine and warrants further investigation.
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